Akie Kimura Yoshikawa (Akie Kimura)

Years Active: 2019-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Akie Kimura Yoshikawa, Kensei Yamaguchi, Kei Muro, Atsuo Takashima, Takashi Ichimura, Daisuke Sakai, Shigenori Kadowaki, Keisho Chin, Toshihiro Kudo, Seiichiro Mitani, Shigehisa Kitano, Dung Thai, Marianna Zavodovskaya, JieJane Liu, Narikazu Boku, Taroh Satoh
Safety and tolerability of andecaliximab as monotherapy and in combination with an anti-PD-1 antibody in Japanese patients with gastric or gastroesophageal junction adenocarcinoma: a phase 1b study. Journal for immunotherapy of cancer 10 (1) (2022)
Akie Kimura Yoshikawa, Daisuke Sakai, Toshihiro Kudo, Naohiro Nishida, Aya Katou, Chiaki Inagaki, Toru Otsuru, Yasuhiro Miyazaki, Koji Tanaka, Tomoki Makino, Tsuyoshi Takahashi, Yukinori Kurokawa, Makoto Yamasaki, Masaki Mori, Yuichiro Doki, Taroh Satoh
Nivolumab-induced interstitial lung disease in a patient with gastric cancer. Oxford medical case reports 2019 (2) (2019)

Akie Kimura Yoshikawa.css-eqlu8i{font-size:small;padding-left:4px;} (Akie Kimura)